You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Axitinib

Showing 26 - 50 of 221
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Axitinib Therapy Management Study

Withdrawn
  • Renal Cell Carcinoma
  • New York, New York
    Pfizer Inc.
Mar 25, 2022

And Use Of Avelumab In Combination With Axitinib For Treatment

Recruiting
  • Advanced Renal Cell Carcinoma
  • Sandwich, Kent, United Kingdom
    Pfizer Ltd
May 23, 2022

Colorectal Tumors Malignant Trial in Philadelphia (Axitinib 5 MG, Hydroxychloroquine Pill, trans arterial chemoembolization)

Recruiting
  • Colorectal Neoplasms Malignant
  • Axitinib 5 MG
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center
May 2, 2022

Metastatic Renal Cell Cancer Trial in United States (Axitinib)

Active, not recruiting
Has Results
  • Metastatic Renal Cell Cancer
  • Axitinib
  • Duarte, California
  • +3 more
Jun 1, 2022

Cervical Cancer Trial in Hong Kong (Avelumab, Axitinib)

Recruiting
  • Cervical Cancer
  • Hong Kong, Hong Kong
    The University of Hong Kong
Feb 23, 2022

Papillary Renal Cell Carcinoma Type 2 Trial in France (Axitinib Oral Tablet [Inlyta], Pembrolizumab Injection [Keytruda])

Recruiting
  • Papillary Renal Cell Carcinoma Type 2
  • Axitinib Oral Tablet [Inlyta]
  • Pembrolizumab Injection [Keytruda]
  • Angers, France
  • +11 more
Aug 26, 2022

Clear Cell Renal Cell Carcinoma, First-line Treatment Trial in Shanghai (AK104, axitinib)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • First-line Treatment
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 16, 2022

International Multicentric Study ARON-1

Recruiting
  • Metastatic Renal Cell Carcinoma (mRCC)
  • pembrolizumab plus axitinib
  • Macerata, Italy
    Ospedale di Macerata, UOC Oncologia
Aug 30, 2022

Kidney Cancer, Renal Cell Carcinoma, Unresectable Renal Cell Carcinoma Trial in United States (Talazoparib, Axitinib)

Recruiting
  • Kidney Cancer
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 8, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

Metastatic Renal Cell Carcinoma Trial in Italy (Axitinib, Nivolumab)

Not yet recruiting
  • Metastatic Renal Cell Carcinoma
  • Brescia, Italy
  • +22 more
Apr 19, 2023

Neoadjuvant Therapy Trial in Nanning (tislelizumab combined with axitinib)

Active, not recruiting
  • Neoadjuvant Therapy
  • tislelizumab combined with axitinib
  • Nanning, Jiangsu, China
    Hongqian Guo
Dec 13, 2021

Advanced Renal Cell Carcinoma Trial in United States (Dalantercept and axitinib, Placebo and axitinib)

Terminated
Has Results
  • Advanced Renal Cell Carcinoma
  • Dalantercept and axitinib
  • Placebo and axitinib
  • Tucson, Arizona
  • +35 more
Sep 12, 2022

Neurofibromatosis Type 2, Vestibular Schwannomas Trial in New York (Axitinib)

Completed
Has Results
  • Neurofibromatosis Type 2
  • Vestibular Schwannomas
  • Axitinib
  • New York, New York
    NYU Langone Medical Center
Nov 24, 2021

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Solitary Fibrous Tumor Trial in Milan (Axitinib)

Completed
  • Solitary Fibrous Tumor
  • Axitinib
  • Milan, MI, Italy
    Fondazione IRCCS Istituto Naazionale dei Tumori
Sep 22, 2021

Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) Trial in Iowa City (Selenomethionine (SLM), Axitinib)

Recruiting
  • Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
  • Selenomethionine (SLM)
  • Axitinib
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Sep 13, 2021

Renal Cell Carcinoma Trial in United States (Nivolumab, Axitinib)

Recruiting
  • Renal Cell Carcinoma
  • Baltimore, Maryland
  • +3 more
Nov 16, 2021

Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
    Retinal Research Institute, LLC
Jun 4, 2023

Advanced NSCLC Trial in China (KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein

Enrolling by invitation
  • Advanced Non-small Cell Lung Cancer
  • KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein Injection)
  • Axitinib
  • Hefei, Anhui, China
  • +5 more
Oct 26, 2022

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

Melanoma Stage IV Trial (Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF), Recombinant

Not yet recruiting
  • Melanoma Stage IV
  • Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)
  • +2 more
  • (no location specified)
Sep 27, 2021

Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Tianjin (Pembrolizumab, Axitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Jul 30, 2021

Japanese RCC Patients Treated With Avelumab Plus Axitinib as

Completed
  • Renal Cell Carcinoma
  • Kurume, Fukuoka, Japan
  • +11 more
Feb 22, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Axitinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Axitinib
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021